Atlas Trials

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT00888173 · COMPLETED

Trial details

NCT number
NCT00888173
Sponsor
Gynecologic Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed AdenocarcinomaEndometrial Mucinous AdenocarcinomaEndometrial Serous AdenocarcinomaEndometrial Squamous Cell CarcinomaEndometrial Transitional Cell CarcinomaEndometrial Undifferentiated CarcinomaRecurrent Uterine Corpus Carcinoma
Start date
2009-07-06
Primary completion
2016-07-16
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.